Table 1 Baseline demographics, clinical measures and frailty indicators for the total sample and the sample stratified by faller status at follow up
Faller status at follow up | |||||
|---|---|---|---|---|---|
All (n = 606) | Not followed up (n = 85) | Non faller (n = 373) | Faller (n = 85) | Recurrent faller (n = 63) | |
Demographic | |||||
Age (years) mean(SD) † | 72.8 (7.2) | 75.6 (8.3) | 71.7(6.6) | 71.6(7.1) | 74.8(7.3) |
Gender (m:f) | 189:416 | 30:55 | 124:243 | 16:74 | 18:46 |
Social class mean(SD) | 3.3 (1.7) | 3.6 (1.8) | 3.2(1.6) | 3.2(1.7) | 3.3(1.6) |
Clinical | |||||
BMI (kg.m2) mean (SD) | 26.8 (4.6) | 26.0 (6.1) | 27.2(4.5) | 26.5(5.2) | 26.2(4.0) |
Polypharmacy % | 48.8 | 56.5 | 40.9 | 50.0 | 70.3 |
Osteoarthritis % | 62.0 | 69.9 | 60.8 | 66.7 | 60.9 |
Parkinson’s %† | 4.8 | 5.9 | 2.7 | 4.4 | 12.5 |
Diabetes % | 8.3 | 9.4 | 7.9 | 6.7 | 4.7 |
Congestive cardiac failure %‡ | 31.2 | 38.8 | 27.8 | 28.9 | 39.1 |
Chronic obstructive pulmonary disease % | 11.2 | 21.2 | 10.4 | 5.6 | 9.4 |
Peripheral vascular disease %‡ | 4.8 | 14.1 | 2.7 | 3.3 | 7.8 |
Cancer % | 3.5 | 4.7 | 3.0 | 3.3 | 1.6 |
Hypertension % | 44.4 | 49.4 | 40.9 | 46.7 | 45.3 |
Atrial fibrillation % | 4.3 | 5.9 | 4.4 | 5.6 | 3.1 |
Frailty % | |||||
Robust | 47.5 | 30.6 | 54.0 | 50.0 | 31.2 |
Pre-frail | 43.2 | 47.1 | 41.1 | 43.3 | 56.2 |
Frail | 8.1 | 22.4 | 4.4 | 6.7 | 10.9 |
Frailty Indicators % | |||||
Weight loss % | 14.9 | 15.3 | 4.1 | 5.5 | 10.9 |
Exhaustion %† | 22.3 | 30.6 | 18.3 | 16.7 | 32.8 |
Weakness %† | 36.0 | 49.4 | 30.0 | 38.9 | 43.8 |
Slow walking velocity %‡ | 10.2 | 22.4 | 7.4 | 6.7 | 18.8 |
Decreased activity levels % | 13.7 | 25.9 | 9.5 | 16.7 | 10.9 |